Results
Awaiting price reaction for this filing.
Dolphin Medical Services reported FY2026 revenue of Rs. 75.01 lakhs, a decline from Rs. 77.94 lakhs in FY2025, representing a 3.8% drop in operations. Despite lower revenue, the company turned profitable with net profit of Rs. 4.19 lakhs compared to a net loss of Rs. 3.38 lakhs in the previous year. EBITDA margin expanded significantly from approximately 5% to over 20% due to cost reduction in Other Expenses (down from Rs. 59.29 lakhs to Rs. 37.41 lakhs). Operating cash flow improved to Rs. 13.60 lakhs positive from negative Rs. 5.97 lakhs. The statutory auditor issued an unmodified (clean) opinion confirming the financial statements give a true and fair view.
Revenue decline is a concern but the company has achieved a turnaround from losses to profitability with improved operational efficiency and cash generation. The clean audit opinion provides assurance to shareholders.